17-63941743-G-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000334.4(SCN4A):​c.4539C>A​(p.Ile1513Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.179 in 1,613,846 control chromosomes in the GnomAD database, including 26,654 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. I1513I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.17 ( 2149 hom., cov: 31)
Exomes 𝑓: 0.18 ( 24505 hom. )

Consequence

SCN4A
NM_000334.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -0.00800

Publications

11 publications found
Variant links:
Genes affected
SCN4A (HGNC:10591): (sodium voltage-gated channel alpha subunit 4) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. It is expressed in skeletal muscle, and mutations in this gene have been linked to several myotonia and periodic paralysis disorders. [provided by RefSeq, Jul 2008]
SCN4A Gene-Disease associations (from GenCC):
  • hyperkalemic periodic paralysis
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Orphanet
  • paramyotonia congenita of Von Eulenburg
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Laboratory for Molecular Medicine
  • SCN4A-related myopathy, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Illumina, ClinGen, PanelApp Australia
  • hypokalemic periodic paralysis, type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • potassium-aggravated myotonia
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • congenital myasthenic syndrome 16
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital myopathy
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • congenital myopathy 22A, classic
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • acetazolamide-responsive myotonia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypokalemic periodic paralysis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myotonia fluctuans
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myotonia permanens
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 17-63941743-G-T is Benign according to our data. Variant chr17-63941743-G-T is described in ClinVar as Benign. ClinVar VariationId is 92863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.008 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.189 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000334.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN4A
NM_000334.4
MANE Select
c.4539C>Ap.Ile1513Ile
synonymous
Exon 24 of 24NP_000325.4P35499

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN4A
ENST00000435607.3
TSL:1 MANE Select
c.4539C>Ap.Ile1513Ile
synonymous
Exon 24 of 24ENSP00000396320.1P35499

Frequencies

GnomAD3 genomes
AF:
0.167
AC:
25329
AN:
151860
Hom.:
2148
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.133
Gnomad AMI
AF:
0.219
Gnomad AMR
AF:
0.167
Gnomad ASJ
AF:
0.213
Gnomad EAS
AF:
0.100
Gnomad SAS
AF:
0.130
Gnomad FIN
AF:
0.159
Gnomad MID
AF:
0.269
Gnomad NFE
AF:
0.192
Gnomad OTH
AF:
0.182
GnomAD2 exomes
AF:
0.166
AC:
41536
AN:
250938
AF XY:
0.168
show subpopulations
Gnomad AFR exome
AF:
0.133
Gnomad AMR exome
AF:
0.146
Gnomad ASJ exome
AF:
0.210
Gnomad EAS exome
AF:
0.0966
Gnomad FIN exome
AF:
0.159
Gnomad NFE exome
AF:
0.193
Gnomad OTH exome
AF:
0.171
GnomAD4 exome
AF:
0.181
AC:
263923
AN:
1461868
Hom.:
24505
Cov.:
37
AF XY:
0.180
AC XY:
130972
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.132
AC:
4431
AN:
33480
American (AMR)
AF:
0.149
AC:
6660
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.217
AC:
5682
AN:
26136
East Asian (EAS)
AF:
0.0890
AC:
3533
AN:
39700
South Asian (SAS)
AF:
0.136
AC:
11694
AN:
86258
European-Finnish (FIN)
AF:
0.160
AC:
8557
AN:
53420
Middle Eastern (MID)
AF:
0.220
AC:
1270
AN:
5768
European-Non Finnish (NFE)
AF:
0.190
AC:
211633
AN:
1111988
Other (OTH)
AF:
0.173
AC:
10463
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
14459
28918
43377
57836
72295
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7244
14488
21732
28976
36220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.167
AC:
25345
AN:
151978
Hom.:
2149
Cov.:
31
AF XY:
0.165
AC XY:
12282
AN XY:
74262
show subpopulations
African (AFR)
AF:
0.134
AC:
5537
AN:
41448
American (AMR)
AF:
0.167
AC:
2549
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.213
AC:
738
AN:
3468
East Asian (EAS)
AF:
0.0998
AC:
515
AN:
5158
South Asian (SAS)
AF:
0.129
AC:
623
AN:
4814
European-Finnish (FIN)
AF:
0.159
AC:
1683
AN:
10552
Middle Eastern (MID)
AF:
0.269
AC:
79
AN:
294
European-Non Finnish (NFE)
AF:
0.192
AC:
13042
AN:
67958
Other (OTH)
AF:
0.179
AC:
379
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1071
2142
3212
4283
5354
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
264
528
792
1056
1320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.185
Hom.:
2080
Bravo
AF:
0.165
Asia WGS
AF:
0.0900
AC:
315
AN:
3478
EpiCase
AF:
0.203
EpiControl
AF:
0.198

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
2
Hyperkalemic periodic paralysis (2)
-
-
2
not provided (2)
-
-
1
Congenital myasthenic syndrome 16 (1)
-
-
1
Hypokalemic periodic paralysis, type 2 (1)
-
-
1
Paramyotonia congenita of Von Eulenburg (1)
-
-
1
Potassium-aggravated myotonia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
0.47
DANN
Benign
0.75
PhyloP100
-0.0080
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56342400; hg19: chr17-62019103; COSMIC: COSV71126087; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.